 |
PDBsum entry 2yz3
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystallographic investigation of inhibition mode of the vim-2 metallo-beta-lactamase from pseudomonas aeruginosa with mercaptocarboxylate inhibitor
|
|
Structure:
|
 |
Metallo-beta-lactamase. Chain: a, b. Synonym: vim-2, metallo-beta-lactamase vim-2, vim-2 beta-lactamase. Engineered: yes
|
|
Source:
|
 |
Pseudomonas putida. Organism_taxid: 303. Gene: vim-2, bla vim-2, blavim-2. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.212
|
R-free:
|
0.247
|
|
|
Authors:
|
 |
Y.Yamaguchi,Y.Yamagata,Y.Arakawa,H.Kurosaki
|
|
Key ref:
|
 |
Y.Yamaguchi
et al.
(2007).
Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor.
J Med Chem,
50,
6647-6653.
PubMed id:
|
 |
|
Date:
|
 |
|
02-May-07
|
Release date:
|
11-Mar-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q7BJM5
(Q7BJM5_PSEPU) -
VIM-2 from Pseudomonas putida
|
|
|
|
Seq: Struc:
|
 |
 |
 |
266 a.a.
225 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
50:6647-6653
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor.
|
|
Y.Yamaguchi,
W.Jin,
K.Matsunaga,
S.Ikemizu,
Y.Yamagata,
J.Wachino,
N.Shibata,
Y.Arakawa,
H.Kurosaki.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The VIM-2 metallo-beta-lactamase enzyme from Pseudomonas aeruginosa catalyzes
the hydrolysis of most beta-lactam antibiotics including carbapenems, and there
are currently no potent inhibitors of such enzymes. We found
rac-2-omega-phenylpropyl-3-mercaptopropionic acid, phenylC3SH, to be a potent
inhibitor of VIM-2. The structure of the VIM-2-phenylC3SH complex was determined
by X-ray crystallography to 2.3 A. The structure revealed that the thiol group
of phenylC3SH bridged to the two zinc(II) ions and the phenyl group interacted
with Tyr67(47) on loop1 near the active site, by pi-pi stacking interactions.
The methylene group interacted with Phe61(42) located at the bottom of loop1
through CH-pi interactions. Dynamic movements were observed in Arg228(185) and
Asn233(190) on loop2, compared with the native structure (PDB code: 1KO3 ).
These results suggest that the above-mentioned four residues play important
roles in the binding and recognition of inhibitors or substrates and in
stabilizing a loop in the VIM-2 enzyme.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Bebrone,
P.Lassaux,
L.Vercheval,
J.S.Sohier,
A.Jehaes,
E.Sauvage,
and
M.Galleni
(2010).
Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
|
| |
Drugs,
70,
651-679.
|
 |
|
|
|
|
 |
G.De Pascale,
and
G.D.Wright
(2010).
Antibiotic resistance by enzyme inactivation: from mechanisms to solutions.
|
| |
Chembiochem,
11,
1325-1334.
|
 |
|
|
|
|
 |
L.Borgianni,
J.Vandenameele,
A.Matagne,
L.Bini,
R.A.Bonomo,
J.M.Frère,
G.M.Rossolini,
and
J.D.Docquier
(2010).
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
|
| |
Antimicrob Agents Chemother,
54,
3197-3204.
|
 |
|
|
|
|
 |
M.Merino,
F.J.Pérez-Llarena,
F.Kerff,
M.Poza,
S.Mallo,
S.Rumbo-Feal,
A.Beceiro,
C.Juan,
A.Oliver,
and
G.Bou
(2010).
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
|
| |
J Antimicrob Chemother,
65,
1950-1954.
|
 |
|
|
|
|
 |
P.Oelschlaeger,
N.Ai,
K.T.Duprez,
W.J.Welsh,
and
J.H.Toney
(2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
|
| |
J Med Chem,
53,
3013-3027.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev,
23,
160-201.
|
 |
|
|
|
|
 |
Y.Yamaguchi,
N.Takashio,
J.Wachino,
Y.Yamagata,
Y.Arakawa,
K.Matsuda,
and
H.Kurosaki
(2010).
Structure of metallo-beta-lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolution.
|
| |
J Biochem,
147,
905-915.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Minond,
S.A.Saldanha,
P.Subramaniam,
M.Spaargaren,
T.Spicer,
J.R.Fotsing,
T.Weide,
V.V.Fokin,
K.B.Sharpless,
M.Galleni,
C.Bebrone,
P.Lassaux,
and
P.Hodder
(2009).
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.
|
| |
Bioorg Med Chem,
17,
5027-5037.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |